Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 3;22(1):128.
doi: 10.1186/s13075-020-02214-y.

Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis

Affiliations

Validation of the suction device Nimble for the assessment of skin fibrosis in systemic sclerosis

Bettina Müller et al. Arthritis Res Ther. .

Abstract

Objectives: Skin fibrosis is a main hallmark of systemic sclerosis (SSc). Clinical assessment is done semi-quantitatively using the modified Rodnan skin score (mRSS). Objective measurements for quantifying skin fibrosis could complement the mRSS to achieve higher reproducibility. The aim of this study was to explore the potential of suction measurements to detect structural changes in the skin that are associated with skin fibrosis.

Methods: This clinical trial included 30 SSc patients and 30 healthy volunteers (HC). We validated a novel suction device-the Nimble-to quantify skin stiffness in comparison to the Cutometer using the OMERACT filter.

Results: A significant difference (p < 0.05) between the skin stiffness of HC and SSc patient groups was found for each location measured. The correlation between the measurements of forearm skin stiffness and the mRSS values was high for the Nimble (r = 0.82) and moderate for the Cutometer (r = 0.58). A ROC analysis showed good ability for the Nimble to distinguish between SSc patients with and without skin involvement (AUC = 0.82). Both suction devices provided excellent reliability in all measurements on HC and SSc patients and proved face validity and feasibility.

Conclusion: Suction devices assessing skin stiffness, such as the Nimble, show clear potential to objectively quantify skin fibrosis in SSc patients and might be promising outcome measures complementing established methods such as the mRSS.

Trial registration: Clinicaltrials.gov, NCT03644225, Registered 23 August 2018-Retrospectively registered, http://www.clinicaltrials.gov.

Keywords: Skin fibrosis; Skin stiffness; Suction measurement; Systemic sclerosis.

PubMed Disclaimer

Conflict of interest statement

Prof. Dr. O. Distler had consultancy relationship and/or has received research funding from Abbvie, Actelion, Acceleron Pharma, Amgen, AnaMar, Baecon Discovery, Blade Therapeutics, Bayer, Boehringer Ingelheim, Catenion, Competitive Drug Development International Ltd., CSL Behring, ChemomAb, Curzion Pharmaceuticals, Ergonex, Galapagos NV, Glenmark Pharmaceuticals, GSK, Inventiva, Italfarmaco, iQone, iQvia, Lilly, medac, Medscape, Mitsubishi Tanabe Pharma, MSD, Novartis, Pfizer, Roche, Sanofi, Target Bio Science, and UCB in the area of potential treatments of scleroderma and its complications. In addition, Prof. Distler has a patent mir-29 for the treatment of systemic sclerosis issued (US8247389, EP2331143). Author Prof. Dr. Edoardo Mazza is coinventor of the related technology, described in the patent: Aspiration Device and Method for Determining Viscoelastic Properties of Biological Tissues and Synthetic Materials, EP16197195.7. The other authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Schemes of the working principles of the Nimble (a) and Cutometer (b) suction devices. The Nimble operates in a displacement-controlled fashion, with negative pressure drawing the skin into the probe opening until it reaches a defined height (h). The outcome measure is the pressure (pcl) needed for the specific tissue elevation. The Cutometer operates in a load-controlled fashion, with negative pressure drawing the skin into the probe opening until a maximum pressure is reached. The outcome measure is the elevation corresponding to a specific suction load. We extracted the maximum elevation (R0 in mm) for our study
Fig. 2
Fig. 2
a Finite element (FE) simulation of suction experiment using a neo-Hookean material model with Young’s modulus E. The 2D cross-sectional geometry is depicted. b Estimated kNimble and kR0 for two materials, M1 and M2, with FE analysis (FE stiffness) and mean (n = 3) of kNimble and kR0 (experimental stiffness). The dotted line indicates the linear relationship between kNimble or kR0 and the Young’s modulus of the material
Fig. 3
Fig. 3
Mean and SEM for HC (white) and SSc (gray) measured with the Nimble (a) and the Cutometer (b) for the four body locations, n = 30 for each group. For all locations and both devices, significant differences were found with a paired t-test (p < 0.0)
Fig. 4
Fig. 4
Skin stiffness score of suction measurements correlated with mRSS values of SSc patients. a Correlation of kSSNimble with mRSS4total of the four measured locations. The first group includes the kSSNimble for the HC group, the second the kSSNimble for the SSc patients with total mRSS4total = 0 and the following grouped in mRSS ranges of: 1 ≤ mRSS4total ≤ 3, 4 ≤ mRSS4total ≤ 6, 7 ≤ mRSS4total ≤ 9 and 10 ≤ mRSS4total ≤ 12. b Correlation of kSSR0 with mRSS4total of the four measured locations
Fig. 5
Fig. 5
a Skin stiffness score (kSS) of Nimble measurements grouped into SSc patients with mRSS4total = 0 and mRSS4total > 0. b Skin stiffness score (kSS) of Cutometer measurements grouped into SSc patients with mRSS4total = 0 and mRSS4total > 0. c Receiver operating characteristic (ROC) curve tests for sensitivity and specificity of suction measures. Nimble measurements showed a larger area under the ROC curve (AUC) compared to Cutometer measurements, indicating a better ability to distinguish between SSc patients with a total mRSS4total = 0 and SSc patients with a total mRSS4total > 0. Cut-off values were evaluated by the Youden’s index, indicated in red

Similar articles

Cited by

References

    1. Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton CP, et al. Systemic sclerosis. Nat Rev Dis Prim. 2015;1(1):15002. doi: 10.1038/nrdp.2015.2. - DOI - PubMed
    1. Khanna D, Merkel PA. Outcome measures in systemic sclerosis: an update on instruments and current research. Curr Rheumatol Rep. 2007;9(2):151–157. doi: 10.1007/s11926-007-0010-5. - DOI - PubMed
    1. Shand L, Lunt M, Nihtyanova S, Hoseini M, Silman A, Black CM, et al. Relationship between change in skin score and disease outcome in diffuse cutaneous systemic sclerosis: application of a latent linear trajectory model. Arthritis Rheum. 2007;56(7):2422–2431. doi: 10.1002/art.22721. - DOI - PubMed
    1. Zheng B, Nevskaya T, Baxter CA, Ramey DR, Pope JE, Baron M, et al. Changes in skin score in early diffuse cutaneous systemic sclerosis are associated with changes in global disease severity. Rheumatology. 2019;59(2):398–406. - PubMed
    1. Domsic RT, Rodriguez-Reyna T, Lucas M, Fertig N, Medsger TA. Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma. Ann Rheum Dis. 2011;70(1):104–109. doi: 10.1136/ard.2009.127621. - DOI - PMC - PubMed

Publication types

Associated data